Press Room Video Gallery Proactive Interview with Cameron Reynolds, President & CEO Proactive Interview with Cameron Reynolds, President & CEO Play video Video gallery Cameron Reynolds speaking about Volition's Assay Development Program Play video An interview with Cameron Reynolds - 2019 Highlights, Octamer Acquisition and Look Ahead to 2020 Play video Volition Announces Strategic Acquisition Play video VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test Play video Volition Announces Proof of Concept Data in Lymphoma and Leukemia Play video Proactive Interview with Cameron Reynolds, President & CEO Play video Third Quarter 2019 Results & Business Update - an interview with Cameron Reynolds Play video Signing Ceremony with interviews from members of the Volition and Texas A&M Teams Play video Proactive Investor Interview Quarter Two Earnings Update Play video
